Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.5%

4 terminated/withdrawn out of 273 trials

Success Rate

90.2%

+3.7% vs industry average

Late-Stage Pipeline

13%

36 trials in Phase 3/4

Results Transparency

3%

1 of 37 completed trials have results

Key Signals

56 recruiting1 with results

Enrollment Performance

Analytics

N/A
92(48.4%)
Phase 2
43(22.6%)
Phase 4
20(10.5%)
Phase 3
16(8.4%)
Phase 1
16(8.4%)
Early Phase 1
3(1.6%)
190Total
N/A(92)
Phase 2(43)
Phase 4(20)
Phase 3(16)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (273)

Showing 20 of 273 trials
NCT07854964Not ApplicableNot Yet Recruiting

A Prospective, Single-center, Phase II Study of Neoadjuvant Serplulimab Plus XELOX and Bevacizumab in Locally Advanced Rectal Cancer

Role: lead

NCT05430802Phase 2Active Not Recruiting

Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE)

Role: lead

NCT06146946Not ApplicableRecruiting

Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)

Role: collaborator

NCT06576921Phase 2Active Not Recruiting

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Role: collaborator

NCT07784686Completed

Feature Analysis of Knee Joint Magnetic Resonance Imaging Based on Artificial Intelligence

Role: lead

NCT07786233Not ApplicableRecruiting

Multi-Field-Strength MRI Brain Atlas Construction in Healthy Chinese Population

Role: lead

NCT07185373Phase 2Recruiting

Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL

Role: collaborator

NCT07773363Phase 2Not Yet Recruiting

Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer

Role: lead

NCT01886222Not ApplicableCompleted

Randomized Controlled Trial of Long-term Mild Hypothermia for Severe Traumatic Brain Injury

Role: collaborator

NCT05792462Phase 1Active Not Recruiting

Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders

Role: collaborator

NCT07752394Phase 2Not Yet Recruiting

Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma

Role: lead

NCT05767164Not ApplicableRecruiting

Correlation Between Parameters and Prognosis of Cervical Single Open-door Surgery

Role: collaborator

NCT06331923Not ApplicableCompleted

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients With Diabetes

Role: collaborator

NCT07721441Enrolling By Invitation

Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）

Role: lead

NCT07709767Phase 2Not Yet Recruiting

Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma

Role: lead

NCT07705126Not Yet Recruiting

A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC

Role: lead

NCT06577792Not ApplicableActive Not Recruiting

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

Role: collaborator

NCT07260773Not ApplicableNot Yet Recruiting

The Effects of Coenzyme Q10 Pretreatment on Ovarian Function and Assisted Reproductive Outcomes in Patients With Ovarian Hyporesponsiveness.

Role: lead

NCT07699770Phase 4Not Yet Recruiting

Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

Role: lead

NCT07683364Not ApplicableNot Yet Recruiting

Bristol Stool Scale-Based Care Pathway for Enteral Nutrition-Associated Diarrhea in Critically Ill Patients

Role: lead